caffeic acid has been researched along with Acute Confusional Senile Dementia in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 15 (78.95) | 24.3611 |
| 2020's | 4 (21.05) | 2.80 |
| Authors | Studies |
|---|---|
| Han, J; Irie, K; Isoda, H; Kurisu, M; Miyamae, Y; Murakami, K; Shigemori, H | 1 |
| Chao, X; Cheng, Z; He, X; Huang, Y; Jin, M; Liu, P; Liu, S; Pi, R; Qin, J; Rapposelli, S; Tan, Y; Wang, Y; Yang, Y; Yu, J; Zhou, X | 1 |
| Hadjipavlou-Litina, D; Marco-Contelles, J; Samadi, A; Unzeta, M | 1 |
| Chen, Z; Chu, J; Digiacomo, M; Han, Y; Lapucci, A; Macchia, M; Pi, R; Rapposelli, S; Wang, S; Yang, X | 1 |
| Chen, J; Chen, Q; Chen, Z; Chu, J; Digiacomo, M; Gu, Q; Han, Y; Macchia, M; Nesi, G; Pi, R; Rapposelli, S; Sestito, S; Tu, Y; Wang, S; Yang, X | 1 |
| Andrisano, V; Apperley, KYP; Bartolini, M; Baschieri, A; Basso, M; Chen, HH; De Simone, A; Guardigni, M; Keillor, JW; Kobrlova, T; Milelli, A; Montanari, S; Soukup, O; Valgimigli, L | 1 |
| Edraki, N; Firuzi, O; Iraji, A; Khoshneviszadeh, M; Mahdavi, M; Miri, R; Nadri, H; Tavakkoli, M | 1 |
| Chan, YT; Charng, JL; Chen, CS; Chen, RJ; Chen, YR; Chen, YS; Fang, JM; Hsu, HT; Lin, TW; Lo, YW; Tsai, YR; Tseng, NH; Tu, LH; Wu, YT | 1 |
| Andrade, S; Loureiro, JA; Pereira, MC | 2 |
| Cao, B; Feng, WS; Hao, FX; Jiao, XM; Liang, XW; Zeng, MN; Zheng, XK | 1 |
| Guan, S; Li, C; Li, H; Ma, L; Wang, L; Yu, X; Zhao, Z | 1 |
| Agunloye, OM; Oboh, G | 1 |
| Chang, W; Huang, D; Huang, W; Kuo, P; Lo, YM; Shen, S; Tee, Q; Wu, JS | 1 |
| Bai, H; Han, B; Hua, L; Li, J; Lou, J; Wang, Y; Yang, X; Yin, H; Zeng, Z; Zhang, Y | 1 |
| Chen, ZW; He, XX; Ou, RY; Ouyang, Y; Pi, RB; Wang, SN; Wen, SJ; Yang, XH | 1 |
| Arai, T; Fukuhara, K; Hara, S; Imai, K; Kurihara, M; Kuwata, H; Miyata, N; Mizuno, M; Mori, K; Nakagawa, H; Ohno, A; Shibanuma, M | 1 |
| Habtemariam, S | 1 |
| Adefegha, SA; Ademiluyi, AO; Agunloye, OM; Akinyemi, AJ; Oboh, G | 1 |
1 review(s) available for caffeic acid and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Protective Effects of Caffeic Acid and the Alzheimer's Brain: An Update.
Topics: Alzheimer Disease; Animals; Brain; Caffeic Acids; Humans | 2017 |
18 other study(ies) available for caffeic acid and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Protective effects of caffeoylquinic acids on the aggregation and neurotoxicity of the 42-residue amyloid β-protein.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cell Line, Tumor; Cell Survival; Humans; Neurons; Peptide Fragments; Protein Multimerization; Protein Structure, Secondary; Quinic Acid; Structure-Activity Relationship | 2012 |
Design, synthesis and pharmacological evaluation of novel tacrine-caffeic acid hybrids as multi-targeted compounds against Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Butyrylcholinesterase; Caffeic Acids; Cell Death; Cell Line; Cholinesterase Inhibitors; Drug Design; Hydrogen Peroxide; Mice; Neurons; Neuroprotective Agents; Tacrine | 2012 |
Analysis of the antioxidant properties of differently substituted 2- and 3-indolyl carbohydrazides and related derivatives.
Topics: Alzheimer Disease; Animals; Antioxidants; Biocatalysis; Biphenyl Compounds; Carrageenan; Edema; Female; Free Radical Scavengers; Humans; Hydrazines; Lipid Peroxidation; Lipoxygenase; Male; Molecular Structure; Oxidation-Reduction; Picrates; Rats; Rats, Inbred F344; Structure-Activity Relationship | 2013 |
Synthesis and pharmacological evaluation of multifunctional tacrine derivatives against several disease pathways of AD.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Aspartic Acid Endopeptidases; Caffeic Acids; Cell Line; Cholinesterase Inhibitors; Coumaric Acids; Drug Design; Humans; Models, Molecular; Structure-Activity Relationship; Tacrine; Thioctic Acid | 2015 |
Discovery of novel rivastigmine-hydroxycinnamic acid hybrids as multi-targeted agents for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Cholinesterase Inhibitors; Coumaric Acids; Drug Discovery; Humans; In Vitro Techniques; Neuroprotective Agents; Rivastigmine; Structure-Activity Relationship | 2017 |
Hydroxy-substituted trans-cinnamoyl derivatives as multifunctional tools in the context of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Cinnamates; Dose-Response Relationship, Drug; Free Radical Scavengers; Glycogen Synthase Kinase 3 beta; Molecular Structure; Stereoisomerism; Structure-Activity Relationship | 2017 |
Multifunctional iminochromene-2H-carboxamide derivatives containing different aminomethylene triazole with BACE1 inhibitory, neuroprotective and metal chelating properties targeting Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Aspartic Acid Endopeptidases; Benzopyrans; Cell Proliferation; Chelating Agents; Dose-Response Relationship, Drug; Humans; Molecular Structure; Neuroprotective Agents; PC12 Cells; Rats; Structure-Activity Relationship; Triazoles | 2017 |
Rationally designed divalent caffeic amides inhibit amyloid-β fibrillization, induce fibril dissociation, and ameliorate cytotoxicity.
Topics: Alzheimer Disease; Amides; Amyloid beta-Peptides; Animals; Caenorhabditis elegans; Caffeic Acids; Humans; Models, Molecular; Peptide Fragments; Protein Multimerization | 2018 |
Caffeic acid for the prevention and treatment of Alzheimer's disease: The effect of lipid membranes on the inhibition of aggregation and disruption of Aβ fibrils.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Benzothiazoles; Caffeic Acids; Circular Dichroism; Fluorescence; Humans; Kinetics; Membrane Lipids; Protein Aggregates; Protein Structure, Secondary; Spectroscopy, Fourier Transform Infrared | 2021 |
Caffeic acid loaded into engineered lipid nanoparticles for Alzheimer's disease therapy.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Blood-Brain Barrier; Endothelial Cells; Liposomes; Nanoparticles; Receptors, Transferrin | 2023 |
[Effect of aqueous extract of Corni Fructus on Aβ_(25-35)-induced brain injury and neuroinflammation in mice with Alzheimer's disease].
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Aspartic Acid; Brain Injuries; Cornus; Cysteine; Disease Models, Animal; Interleukin-6; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Molecular Docking Simulation; Neuroinflammatory Diseases; Peptide Hydrolases; Tumor Necrosis Factor-alpha | 2023 |
Caffeic acid protects against Aβ toxicity and prolongs lifespan in
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Caenorhabditis elegans; Caffeic Acids; Chemotaxis; Gene Expression Regulation; Longevity; Molecular Structure; Ovum; Reactive Oxygen Species | 2021 |
Modulatory effect of caffeic acid on cholinesterases inhibitory properties of donepezil.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Butyrylcholinesterase; Caffeic Acids; Cholinesterase Inhibitors; Donepezil; Drug Synergism; Drug Therapy, Combination; Humans; Indans; Male; Nootropic Agents; Piperidines; Rats; Rats, Wistar | 2017 |
Protective Effect of Caffeic Acid against Alzheimer's Disease Pathogenesis via Modulating Cerebral Insulin Signaling, β-Amyloid Accumulation, and Synaptic Plasticity in Hyperinsulinemic Rats.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Brain; Caffeic Acids; Cerebral Cortex; Diet, High-Fat; Disease Models, Animal; Glutathione; Glycogen Synthase Kinase 3 beta; Hippocampus; Hyperinsulinism; Insulin; Male; Neuronal Plasticity; Phosphorylation; Rats; Rats, Sprague-Dawley; Signal Transduction; Superoxide Dismutase; tau Proteins | 2019 |
Effects of caffeic acid on learning deficits in a model of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Blotting, Western; Brain; Caffeic Acids; Caspase 3; Cognition; Disease Models, Animal; Inflammation; Learning Disabilities; Male; Maze Learning; Nitrites; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Random Allocation; Rats, Sprague-Dawley; Transcription Factor RelA; Tumor Suppressor Protein p53 | 2016 |
Synthesis and evaluation of multifunctional ferulic and caffeic acid dimers for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Biphenyl Compounds; Caffeic Acids; Cell Death; Cell Line; Coumaric Acids; Free Radical Scavengers; Glutamic Acid; Humans; Mice; Neurons; Peptide Fragments; Picrates | 2017 |
Inhibition of amyloid fibril formation and cytotoxicity by caffeic acid-conjugated amyloid-β C-terminal peptides.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Antioxidants; Caffeic Acids; Cell Line, Tumor; Humans; Neuroprotective Agents; Oxidative Stress; Peptide Fragments; Protein Aggregates | 2016 |
Comparative study on the inhibitory effect of caffeic and chlorogenic acids on key enzymes linked to Alzheimer's disease and some pro-oxidant induced oxidative stress in rats' brain-in vitro.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Brain; Butyrylcholinesterase; Caffeic Acids; Chlorogenic Acid; Cholinesterase Inhibitors; Male; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species | 2013 |